How to manage a long-standing painful keloid in a patient with chronic symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Long-Standing Painful Keloids

For a keloid that has been present for years and has become painful, initiate intralesional triamcinolone acetonide injections at 40 mg/mL as first-line therapy, with repeat injections every 4-6 weeks until symptom resolution or flattening occurs. 1, 2, 3

Initial Assessment and Treatment Planning

When evaluating a chronic painful keloid, confirm the diagnosis clinically by identifying a raised, firm scar extending beyond the original wound margins with associated pain or pruritus. 4 The pain in long-standing keloids typically indicates active inflammation and ongoing collagen proliferation, making these lesions particularly responsive to corticosteroid therapy. 3

First-Line Treatment: Intralesional Corticosteroids

Triamcinolone Acetonide Protocol

  • Inject triamcinolone acetonide at 40 mg/mL concentration directly into the keloid using strict aseptic technique. 1, 2 Higher concentrations (40 mg/mL) are specifically recommended for keloids rather than lower concentrations used for hypertrophic scars. 1

  • Administer injections every 4-6 weeks, continuing until the keloid flattens or symptoms resolve. 3 Response rates range from 50-100% regression, though this is variable. 3

  • Expect pain relief within days to weeks after the first injection, as corticosteroids rapidly reduce inflammation and inhibit collagen synthesis. 3

Monitoring for Adverse Effects

Watch for local complications at each follow-up visit, including:

  • Skin atrophy (thinning at injection site) 1
  • Pigmentary changes (hypopigmentation or hyperpigmentation) 1
  • Telangiectasias (visible small blood vessels) 1
  • Hypertrichosis (excessive hair growth) 1

With repeated injections, assess for systemic corticosteroid absorption, particularly if treating large or multiple keloids. 1

Second-Line and Combination Therapies

If Inadequate Response to Triamcinolone Alone

Combine triamcinolone acetonide with 5-fluorouracil (5-FU) intralesional injections. 3 This combination is more effective than either agent alone and shows fewer side effects compared to monotherapy. 3 The synergistic effect addresses both inflammation and abnormal fibroblast proliferation. 5

Alternative: Triamcinolone Plus Verapamil

Consider combining triamcinolone with verapamil for patients who fail monotherapy. 3 This combination achieves statistically significant improvements with long-term stable results, though triamcinolone alone shows faster initial response. 3

Surgical Considerations for Refractory Cases

When to Consider Excision

Reserve surgical excision for keloids that fail medical management after 6-12 months of intralesional therapy. 6, 7 Surgery alone carries high recurrence rates (27% overall, 74% in those followed >1 year). 6

Excision Plus Adjuvant Therapy

If surgery is necessary:

  • Perform complete excision followed immediately by adjuvant radiation therapy to reduce recurrence risk. 6, 5 However, evidence remains equivocal, with recurrence rates still substantial even with this aggressive approach. 6

  • Alternatively, use CO2 laser resection allowing healing by secondary intention, followed by early detection and treatment of recurrence with triamcinolone 40 mg/mL via dermajet injection. 7 This protocol achieved 84% control rates in compliant patients. 7

Critical Pitfalls to Avoid

Never perform surgical excision without planning for adjuvant therapy, as surgery alone has unacceptably high recurrence rates. 6, 5 Most recurrences occur more than 1 year after treatment, necessitating long-term follow-up. 6

Do not inject triamcinolone subcutaneously or superficially—the injection must be intralesional (directly into the keloid tissue) to be effective. 2 Subcutaneous injection causes fat atrophy without treating the keloid. 2

Warn patients with keloid history to avoid elective procedures causing skin trauma, as prevention is the most effective strategy. 1 Any future injury may trigger new keloid formation. 1

Treatment Algorithm for Painful Chronic Keloids

  1. Start with intralesional triamcinolone acetonide 40 mg/mL every 4-6 weeks 1, 2, 3
  2. If partial response after 3 injections, add 5-FU to the triamcinolone regimen 3
  3. If no response after 6 months of combination therapy, consider surgical excision with adjuvant radiation 6, 5
  4. Monitor all patients for at least 2 years post-treatment, as late recurrences are common 6, 7

Managing Infection Risk

If the keloid surface is broken or shows signs of secondary infection, add topical or systemic antibiotics before initiating corticosteroid therapy. 1 Corticosteroids can mask infection and impair healing if infection is present. 1

References

Guideline

Keloid Management: Treatment Options

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and Treatment of Keloid: Method Summary and Effect Evaluation.

Clinical, cosmetic and investigational dermatology, 2023

Research

Medical and surgical therapies for keloids.

Dermatologic therapy, 2004

Research

An approach to management of keloids.

Archives of otolaryngology--head & neck surgery, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.